CART-123
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CART-123, covering 2018-06-14 to 2018-06-14. Get the full timeline:
Most recent: Clinical Trial Update: CART-123 FOR Relapsed/Refractory Acute Myelocytic Leukemia（AML） [Phase 1, Phase 2]